Pathways
Muscular Dystrophies and Dystrophin-Glycoprotein Complex
Description:
Muscular dystrophy is a genetically heterogeneous group of disorders characterized by progressive weakness and degeneration of the skeletal or voluntary muscles which control movement. This group of diseases has three features in common: they are hereditary, they are progressive and each causes a characteristic, selective pattern of weakness. Some forms of MD first appear in infancy or childhood, but others may not appear until middle age or later. Although the actual cause of this disorder is unknown, it is known that a gene...
References:
-
Duchenne Muscular Dystrophy.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.2018 Feb 10. -
New treatment alternatives for Duchenne and Becker muscular dystrophy.
Neurology. 2004 Mar 23; 62(6):E10. -
The dystrophin-glycoprotein complex in the prevention of muscle damage.
J Biomed Biotechnol. 2011; 2011:210797. doi: 10.1155/2011/210797. Epub 2011 Oct 5. Review. -
The evolution of the dystroglycan complex, a major mediator of muscle integrity.
Biol Open. 2015 Aug 28; 4(9):1163-79. doi: 10.1242/bio.012468.
You can view details of this pathway by subscribing:
9853 Pacific Heights Blvd.
Suite D., San Diego, CA 92121, USA
Tel: 858-224-2869
Fax: 858-205-1192
info@proteinlounge.com
Databases
Tools
Institutional License
Need our databases and tools to be availed by your whole university or institute? We recommend signing up for our Site License.
To set up a license, please contact: info@proteinlounge.com
Copyright © Protein Lounge Inc.
Terms & Conditions